Types of DMFs & FDA Clarity on DMF Type III (Packaging Materials)
FDA Drug Master File (DMF) Type III
If you are planning to enter the US market, understanding Drug Master Files is not optional. A wrong approach can delay approvals, create compliance risks, and impact your business timelines.
This guide explains the types of DMFs, with a clear focus on DMF Type III, which is critical for packaging materials. You will also learn when you actually need it and how to avoid common mistakes.
If you are unsure about your DMF strategy, you can speak with our experts for practical guidance.
Talk to Our Expert
What is a Drug Master File (DMF)?
A Drug Master File is a confidential submission to the US FDA that contains detailed information about facilities, processes, materials, or packaging used in manufacturing drugs.
How many types of DMF are there?
There are four commonly used types:
- Type II for drug substances
- Type III for packaging materials
- Type IV for excipients
- Type V for reference information
What is DMF Type III?
DMF Type III includes information about packaging materials like bottles, closures, blister packs, and containers that come in direct contact with drug products.
Why DMF Strategy Matters
Many companies misunderstand when and how to use DMFs. This often leads to:
- Delays in FDA submissions
- Rejections due to incomplete or incorrect data
- Exposure of confidential information
- Loss of potential clients due to regulatory gaps
A clear DMF strategy helps you protect your data while ensuring smooth regulatory approval.
Types of Drug Master Files (DMF)
Type II DMF – Drug Substance
This type covers active pharmaceutical ingredients and intermediates. It is widely used in ANDA and NDA submissions.
Type III DMF – Packaging Material
This is used for packaging components that come in direct contact with drugs. It includes items like bottles, caps, closures, vials, and blister packs.
It is especially useful when the manufacturer wants to keep material composition confidential while still supporting multiple clients.
Type IV DMF – Excipients
This includes inactive ingredients used in drug formulation. It helps protect proprietary formulation details.
Type V DMF – Reference Information
This is used for specific reference information accepted by the FDA. It is less commonly used compared to other types.
What is the Definition of Primary Packaging Materials?
Primary packaging materials are the materials that come into direct contact with pharmaceutical products, such as tablets, capsules, liquids, or powders. Their main role is to protect the drug from contamination, physical damage, and chemical degradation during storage, transportation, and use.
In the pharmaceutical industry, packaging is categorized into three levels:
- Primary packaging (direct contact with the product)
- Secondary packaging (outer labeling and bundling)
- Tertiary packaging (bulk transport handling)
Also Read Medical Device Packaging.
Purpose of Primary Packaging
The primary objectives of primary packaging include:
- Containment of the drug
- Protection against physical, chemical, and environmental factors
- Portion control for accurate dosage
- Security from tampering and contamination
Also known as sales packaging, primary packaging plays a critical role not just in protection but also in consumer usability and product presentation. Since it directly touches the product, any defect in packaging can affect drug stability and safety potentially harming the end user.
Need Help With Type III DMF Submission?
When Do You Need DMF Type III?
You should consider filing a DMF Type III if:
- You manufacture packaging materials for pharmaceutical companies
- Your packaging directly interacts with the drug product
- You want to protect confidential composition or manufacturing details
- You supply packaging to multiple clients
- You are exporting packaging materials to the US market
However, if all packaging details are already shared directly in an NDA or ANDA, a DMF may not be required.
Our DMF Type III Consulting Services
We support pharmaceutical and packaging companies with complete DMF solutions.
- DMF Preparation and Documentation
We prepare structured, FDA-aligned documentation to support your submission.
- Gap Assessment
We review your existing data and identify missing or weak areas before filing.
We guide you through the complete submission process to reduce delays.
- DMF Lifecycle Management
We help with updates, amendments, and long-term compliance.
Why Choose Us
- Strong experience in US FDA regulatory consulting
- Support for manufacturers, exporters, and startups
- Practical approach focused on approvals, not just documentation
- Faster turnaround with expert guidance
FAQ
Is DMF mandatory for FDA submission?
No, DMF is not mandatory. It is used to share confidential information with the FDA without disclosing it to other parties.
Who files a DMF Type III?
Packaging material manufacturers or suppliers usually file DMF Type III.
What is a Letter of Authorization (LOA)?
An LOA allows the FDA to review a DMF in support of another company’s application.